Adapthealth Corp Stock Price, News & Analysis

AdaptHealth (NASDAQ: AHCO) will release third quarter 2025 financial results before market open on Tuesday, November 4, 2025. Management will host a teleconference at 8:30 a.m. ET for analysts and investors to discuss results and business activities. Participants may dial (800) 343-4849 (Domestic) or (203) 518-9848 (International) and reference Conference ID: AHCO2Q25.

A webcast requires registration and a replay will be available for six months on the company's Investor Relations site at www.adapthealth.com.

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, will participate in the Jefferies Healthcare Services Conference in Nashville on September 29, 2025. The company will engage in a fireside chat at 11:30 a.m. CST, with the webcast available on their website.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 630 locations in 47 states. The company partners with various healthcare providers and serves Medicare, Medicaid, and commercial insurance beneficiaries.

AdaptHealth (NASDAQ: AHCO), a national healthcare-at-home solutions provider, reported Q2 2025 financial results with net revenue of $800.4M, down 0.7% year-over-year. The company posted net income of $14.7M, compared to $19.4M in Q2 2024, and Adjusted EBITDA of $155.5M, a 5.9% decrease.

The company updated its FY2025 guidance, projecting revenue of $3.18B to $3.26B and Adjusted EBITDA of $642M to $682M. Notable achievements include completing sales of certain incontinence and infusion assets, improving cash flow from operations to $257.5M, and securing a new capitated partnership with a major national healthcare system.

AdaptHealth (NASDAQ: AHCO) has secured a significant 5-year exclusive partnership with a major national healthcare system to provide home medical equipment and supplies. The agreement, structured primarily as a capitation payment model, will serve over 10 million members across Medicare Advantage, Medicaid Managed Care, and privately insured patients.

AdaptHealth, which currently serves approximately 4.2 million patients annually through 630 locations in 47 states, will expand its reach through this partnership. The company operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, providing essential medical equipment and services to patients nationwide.

AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, announced its participation in the Canaccord Genuity 45th Annual Growth Conference in Boston. The company will engage in a fireside chat on Wednesday, August 13, 2025, at 8:00 AM ET.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 660 locations in 47 states. The company partners with various healthcare providers and serves Medicare, Medicaid, and commercial insurance beneficiaries.

AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, before market open.

The company will host an earnings conference call at 8:30 a.m. ET on the same day. Investors can join via phone using the numbers (800) 343-4136 (Domestic) or (203) 518-9843 (International) with Conference ID: AHCO2Q25. A webcast replay will be available on AdaptHealth's investor relations website for six months following the live call.

AdaptHealth Corp. (NASDAQ: AHCO), a national healthcare-at-home solutions provider, has completed the previously announced sale of certain infusion assets from its Wellness at Home segment. The divested assets generated approximately $52 million in annual revenue and $5 million in annual Adjusted EBITDA.

Following the transaction, AdaptHealth used the proceeds along with other funds to make a $65 million prepayment on its outstanding term loan. This follows a previous $70 million prepayment in May 2025, which was primarily funded through the sale of certain incontinence assets.

In light of these changes, the company has revised its full-year 2025 guidance: revenue is now expected between $3,150-$3,290 million, Adjusted EBITDA between $662-$702 million, and Free Cash Flow between $170-$190 million. The company projects $30 million in cash taxes due on gains from this disposition.

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, has announced its participation in two upcoming investor conferences. The company will attend the Barclays Leveraged Finance Conference in Austin on May 20, 2025, and the RBCCM Global Healthcare Conference in New York on May 21, 2025, where they will participate in a fireside chat at 8:00 a.m. ET.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 660 locations in 47 states. The company partners with various healthcare providers and serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.

AdaptHealth Corp. (NASDAQ: AHCO) reported its Q1 2025 financial results, showing mixed performance. Net revenue decreased 1.8% to $777.9 million compared to $792.5 million in Q1 2024. The company reported a net loss of $7.2 million, wider than the $2.1 million loss in the previous year. Adjusted EBITDA declined 19.3% to $127.9 million. However, cash flow from operations improved to $95.5 million from $49.0 million. The company announced the sale of certain incontinence assets and signed an agreement to sell infusion assets from its Wellness at Home segment. Due to these dispositions, AdaptHealth updated its FY2025 guidance, now expecting revenue of $3.18-3.32 billion and Adjusted EBITDA of $665-705 million. The company serves approximately 4.2 million patients across 50 states through 660 locations.